hydroxycitric acid has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dallera, L; Giorgio, M; Monzani, S; Pallavi, R; Pasqualato, S; Stendardo, M; Verrelli, D | 1 |
1 other study(ies) available for hydroxycitric acid and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Hydroxycitric Acid Inhibits Chronic Myelogenous Leukemia Growth through Activation of AMPK and mTOR Pathway.
Topics: AMP-Activated Protein Kinases; Citrates; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; TOR Serine-Threonine Kinases | 2022 |